Generic Semaglutide Pricing Could Disrupt Global Markets
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
Competition Commission Pharma Probe Expands Scope
The Competition Commission has initiated an early-stage investigation into several pharmaceutical manufacturers following a complaint from the national health department. The companies named include Ascendis, Pharma Q and Sonke, all of which supply medicines to the state…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
Barrs Pharmaceuticals Secures R92m Hetero Investment
Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
Generic Semaglutide Set to Disrupt Global GLP‑1 Market
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.